Vibrosense Dynamics AB Stock

Equities

VSD B

SE0006852125

Medical Equipment, Supplies & Distribution

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-07-07 pm EDT 5-day change 1st Jan Change
0.862 SEK -2.27% Intraday chart for Vibrosense Dynamics AB -1.15% -88.72%
Sales 2022 1.48M 140K Sales 2023 1.81M 172K Capitalization 67.62M 6.39M
Net income 2022 -7M -662K Net income 2023 -7M -662K EV / Sales 2022 97.4 x
Net cash position 2022 8M 756K Net cash position 2023 10.71M 1.01M EV / Sales 2023 31.4 x
P/E ratio 2022
-19 x
P/E ratio 2023
-8.2 x
Employees 3
Yield 2022 *
-
Yield 2023
-
Free-Float 67.51%
More Fundamentals * Assessed data
Dynamic Chart
Vibrosense Dynamics AB Receives New Patent in China CI
Vibrosense Dynamics AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Vibrosense Dynamics AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Vibrosense Dynamics AB) Introduces Diabetic Foot Screening as Standard in the Clinical Operations CI
VibroSense Dynamics AB Receives Provisional Patent Protection for Predition of Nerve Damage Caused by Chemotherapy CI
VibroSense Submits Application for Regulatory Approval in China CI
Vibrosense Dynamics AB Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Certain Series B Shares of Vibrosense Dynamics AB are subject to a Lock-Up Agreement Ending on 12-SEP-2023. CI
Vibrosense Dynamics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023 CI
Vibrosense Dynamics AB Announces Diabetic Foot Screening Is Now Available At the Insurance Clinic At Sophiahemmet in Stockholm CI
Vibrosense Dynamics AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Vibrosense Dynamics AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
VibroSense Dynamics Receives the First Order from Finland CI
Vibrosense Dynamics AB Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Vibrosense Dynamics AB Announces Recognized Diabetes Clinic in Germany Evaluates VibroSense Meter II CI
More news
1 day-2.27%
1 week-1.15%
Current month-1.15%
1 month-8.30%
3 months-44.92%
6 months-88.66%
Current year-88.72%
More quotes
1 week
0.86
Extreme 0.86
0.91
1 month
0.79
Extreme 0.79
0.95
Current year
0.79
Extreme 0.79
8.58
1 year
0.79
Extreme 0.79
8.58
3 years
0.79
Extreme 0.79
25.00
5 years
0.79
Extreme 0.79
25.00
10 years
0.79
Extreme 0.79
40.60
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Founder 67 04-12-31
Members of the board TitleAgeSince
Founder 67 04-12-31
Chairman 57 18-09-30
Director/Board Member 64 -
More insiders
Date Price Change Volume
24-07-07 0.862 -2.27% 19 490
24-07-05 0.882 +0.23% 4,286
24-07-04 0.88 +1.38% 69,502
24-07-03 0.868 -1.36% 49,603
24-07-02 0.88 +0.92% 2,663

End-of-day quote NORDIC GROWTH MARKET, July 07, 2024

More quotes
VibroSense Dynamics AB is a manufacturer of medical instruments. The Company is located in Malmo, Sweden. It is focused on providing efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibers and nerve trunks in the legs and arms.
Calendar
More about the company